Reuters Market Eye - Shares in Astrazeneca Pharma India
The British paper cited senior investment bankers and industry sources saying that informal conversations about a deal had taken place between the two, but that no talks were currently under way after AstraZeneca resisted the approach.
Pfizer and AstraZeneca both declined to comment on the Sunday Times report to Reuters.
Astrazeneca holds a 75 percent stake in its Indian subsidiary, BSE data shows.
(Reporting by Abhishek Vishnoi)


